Latest News and Press Releases

Cellectis reçoit l’accord de la FDA pour démarrer un essai clinique pour UCART20x22 pour les patients atteints de lymphome non-hodgkinien en rechute ou réfractaireCellectis dévoile une nouvelle CAR...

TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the second...

Increased Net Sales 7.3 percent to $333.2 million Earned Net Income per Diluted Share of $0.17 Generated Adjusted Net Income per Diluted Share of $0.19   ATLANTA, Aug. 04, 2022 (GLOBE NEWSWIRE) --...

DENVER, Aug. 04, 2022 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading service commerce platform, today announced that management will present at the following upcoming investor...

Denver, CO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid", the "Company", "we", "us", "our") (NYSE:IPI) today reported its results for the second quarter of 2022. Key...

  IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin LymphomaCellectis unveiled novel immune-evasive universal allogeneic CAR T-cell in Nature Communications; awarded...

Quarterly Sales of $250.8 million, EPS $0.08, Adjusted EPS $0.13Increased pricing with majority of our customers in second half of 2022 NEW ALBANY, Ohio, Aug. 04, 2022 (GLOBE NEWSWIRE) -- CVG...

Reported positive initial data from ongoing pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric low-grade glioma (pLGG); topline results for full pivotal study population expected...

BETHESDA, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST), the nation's largest lodging real estate investment trust (the "Company"), today provided an updated...

NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATES Q2 2022 Financial Highlights(1): Revenues increased by 15.0% to $870.7 millionGross Margin at 11.8%Adjusted EBITDA(3) amounted to $52.1...